论文信息 - CYP2C19*2 predicts substantial tamoxifen benefit in postmenopausal breast cancer patients randomized between adjuvant tamoxifen and no systemic treatment - 字舞流文

CYP2C19*2 predicts substantial tamoxifen benefit in postmenopausal breast cancer patients randomized between adjuvant tamoxifen and no systemic treatment

P. V. van Diest | E. Berns | T. Severson | M. Hauptmann | S. Linn | E. Berns | K. Beelen | R. V. van Schaik | R. V. Schaik | R. Koornstra | J. Vermorken | A. Vincent | M. Opdam | P. V. Diest | R. Koornstra | Andrew Vincent